Phase 2b Prader-Willi Syndrome Trial Ends in Disappointment
According to a story from Malvern Daily Record, the biopharmaceutical company Millendo Therapeutics, Inc. recently released data from its phase 2b clinical trial. This study was testing the company's experimental…